New Formulation Suba-Itraconazole Prophylaxis in Patients with Haematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Lindsay, Julian [1 ]
Sandaradura, Indy [2 ]
Wong, Kelly [3 ]
Arthur, Christopher [3 ]
Stevenson, William [4 ]
Kerridge, Ian [4 ]
Fay, Keith [3 ]
Coyle, Luke [5 ]
Greenwood, Matthew [3 ]
机构：
[1] Royal North Shore Hosp, Hematol, Sydney, NSW, Australia
[2] St Vincents Hlth Network, Pharmacology, Sydney, NSW, Australia
[3] Royal North Shore Hosp, Dept Haematol, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Royal North Shore Hosp, Haematol, Sydney, NSW, Australia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
404
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [1] Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
    Lindsay, Julian
    Sandaradura, Indy
    Wong, Kelly
    Arthur, Chris
    Stevenson, William
    Kerridge, Ian
    Fay, Keith
    Coyle, Luke
    Greenwood, Matthew
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (12) : 3414 - 3419
  • [2] Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies
    Nield, Blake
    Larsen, Stephen R.
    van Hal, Sebastiaan J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (10) : 3049 - 3055
  • [3] SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
    Lindsay, Julian
    Othman, Jad
    Kong, Yvonne
    Yip, Annie
    Van Hal, Sebastiaan
    Larsen, Stephen
    Bryant, Christian
    Gibson, John
    Kerridge, Ian
    Fay, Keith
    Stevenson, William
    Arthur, Chris
    Chen, Sharon C. A.
    Kong, David C. M.
    Greenwood, Matthew
    Pergam, Steven A.
    Liu, Catherine
    Slavin, Monica A.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (11):
  • [4] Antifungal prophylaxis with itraconazole oral solution in patients undergoing allogeneic hematopoietic stem cell transplantation
    Skoetz, N
    Fuchs, M
    Holtick, U
    Scheid, C
    Diehl, V
    Waldschmidt, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S192 - S192
  • [5] Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy
    Slavin, M. A.
    Heath, C. H.
    Thursky, K. A.
    Morrissey, C. O.
    Szer, J.
    Ling, L. M.
    Milliken, S. T.
    Grigg, A. P.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (6B) : 468 - 476
  • [6] Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy
    Slavin, M. A.
    Heath, C. H.
    Thursky, K. A.
    Morrissey, C. O.
    Szer, J.
    Ling, L. M.
    Milliken, S. T.
    Grigg, A. P.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (06) : 468 - 476
  • [7] Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders
    Foot, ABM
    Veys, PA
    Gibson, BES
    BONE MARROW TRANSPLANTATION, 1999, 24 (10) : 1089 - 1093
  • [8] Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders
    ABM Foot
    PA Veys
    BES Gibson
    Bone Marrow Transplantation, 1999, 24 : 1089 - 1093
  • [9] Outcome of allogeneic blood stem cell transplantation for advanced haematological malignancy
    Miflin, G
    Byrne, JL
    Stainer, CJ
    Haynes, AP
    Russell, NH
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 316 - 317
  • [10] Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy
    Huugen, D
    Bos, GMJ
    Jansen, M
    Lalisang, R
    Jansen, R
    Wagstaff, J
    Schouten, HC
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (04): : 170 - 173
12345